11β-HSD2 Antibodies

Santa Cruz Biotechnology features a diverse variety of 11β-HSD2 monoclonal antibodies for research focused on understanding 11β-hydroxysteroid dehydrogenase type 2. Multiple applications are supported, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). 11β-HSD2 serves as a key regulator in controlling local glucocorticoid availability by converting active cortisol to its inactive form, cortisone. The enzyme maintains mineralocorticoid receptor specificity and plays an essential role in kidney function and blood pressure regulation. Research has shown that abnormal 11β-HSD2 activity contributes to various health conditions, including hypertension and metabolic disorders. Understanding 11β-HSD2 function continues to reveal new insights into both normal physiology and disease development. The relationship between 11β-HSD2 and blood pressure regulation represents an active area of investigation in cardiovascular research. Ongoing studies examine how 11β-HSD2 influences hormone signaling pathways and cellular responses. Santa Cruz Biotechnology monoclonal antibodies for 11β-HSD2 research support scientists worldwide in advancing our understanding of human health and disease mechanisms.